258 related articles for article (PubMed ID: 37038186)
1. iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors.
Bogomiakova ME; Sekretova EK; Anufrieva KS; Khabarova PO; Kazakova AN; Bobrovsky PA; Grigoryeva TV; Eremeev AV; Lebedeva OS; Bogomazova AN; Lagarkova MA
Stem Cell Res Ther; 2023 Apr; 14(1):77. PubMed ID: 37038186
[TBL] [Abstract][Full Text] [Related]
2. Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells.
Song C; Wang L; Li Q; Liao B; Qiao W; Li Q; Dong N; Li L
Stem Cell Res Ther; 2022 Feb; 13(1):48. PubMed ID: 35109922
[TBL] [Abstract][Full Text] [Related]
3. Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity.
Flahou C; Morishima T; Takizawa H; Sugimoto N
Front Immunol; 2021; 12():662360. PubMed ID: 33897711
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives.
Bogomiakova ME; Bogomazova AN; Lagarkova MA
Biochemistry (Mosc); 2024 May; 89(5):799-816. PubMed ID: 38880643
[TBL] [Abstract][Full Text] [Related]
5. Generation of universal natural killer cells from a cryopreserved cord blood mononuclear cell-derived induced pluripotent stem cell library.
Du W; Cui L; Zhang J; Zhang H; Liu R; Yang W; Zhang Y
FEBS Open Bio; 2022 Oct; 12(10):1771-1781. PubMed ID: 35747945
[TBL] [Abstract][Full Text] [Related]
6. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
7. NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs.
Ichise H; Nagano S; Maeda T; Miyazaki M; Miyazaki Y; Kojima H; Yawata N; Yawata M; Tanaka H; Saji H; Masuda K; Kawamoto H
Stem Cell Reports; 2017 Sep; 9(3):853-867. PubMed ID: 28867344
[TBL] [Abstract][Full Text] [Related]
8. Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1.
Kruse V; Hamann C; Monecke S; Cyganek L; Elsner L; Hübscher D; Walter L; Streckfuss-Bömeke K; Guan K; Dressel R
PLoS One; 2015; 10(5):e0125544. PubMed ID: 25950680
[TBL] [Abstract][Full Text] [Related]
9. Enhanced wound healing promotion by immune response-free monkey autologous iPSCs and exosomes vs. their allogeneic counterparts.
Lu M; Peng L; Ming X; Wang X; Cui A; Li Y; Wang X; Meng D; Sun N; Xiang M; Chen S
EBioMedicine; 2019 Apr; 42():443-457. PubMed ID: 30926422
[TBL] [Abstract][Full Text] [Related]
10. Generation of Monkey Induced Pluripotent Stem Cell-Derived Cartilage Lacking Major Histocompatibility Complex Class I Molecules on the Cell Surface.
Okutani Y; Abe K; Yamashita A; Morioka M; Matsuda S; Tsumaki N
Tissue Eng Part A; 2022 Jan; 28(1-2):94-106. PubMed ID: 34182799
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
12. Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells.
Flahou C; Morishima T; Higashi N; Hayashi Y; Xu H; Wang B; Zhang C; Ninomiya A; Qiu WY; Yuzuriha A; Suzuki D; Nakamura S; Manz M; Kaneko S; Hotta A; Takizawa H; Eto K; Sugimoto N
Biochem Biophys Res Commun; 2023 Jun; 662():76-83. PubMed ID: 37099813
[TBL] [Abstract][Full Text] [Related]
13. Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I
Chimienti R; Baccega T; Torchio S; Manenti F; Pellegrini S; Cospito A; Amabile A; Lombardo MT; Monti P; Sordi V; Lombardo A; Malnati M; Piemonti L
Cell Rep; 2022 Sep; 40(13):111423. PubMed ID: 36170817
[TBL] [Abstract][Full Text] [Related]
14. T-Cell Mediated Immune Rejection of Beta-2-Microglobulin Knockout Induced Pluripotent Stem Cell-Derived Kidney Organoids.
Gaykema LH; van Nieuwland RY; Lievers E; Moerkerk WBJ; de Klerk JA; Dumas SJ; Kers J; Zaldumbide A; van den Berg CW; Rabelink TJ
Stem Cells Transl Med; 2024 Jan; 13(1):69-82. PubMed ID: 37843402
[TBL] [Abstract][Full Text] [Related]
15. Differential role of natural killer group 2D in recognition and cytotoxicity of hepatocyte-like cells derived from embryonic stem cells and induced pluripotent stem cells.
Cisneros T; Dillard DW; Qu X; Arredondo-Guerrero J; Castro M; Schaffert S; Martin R; Esquivel CO; Krams SM; Martinez OM
Am J Transplant; 2019 Jun; 19(6):1652-1662. PubMed ID: 30549427
[TBL] [Abstract][Full Text] [Related]
16. Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.
Goldenson BH; Zhu H; Wang YM; Heragu N; Bernareggi D; Ruiz-Cisneros A; Bahena A; Ask EH; Hoel HJ; Malmberg KJ; Kaufman DS
Front Immunol; 2020; 11():561553. PubMed ID: 33178188
[TBL] [Abstract][Full Text] [Related]
17. Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey.
Wang X; Lu M; Tian X; Ren Y; Li Y; Xiang M; Chen S
Stem Cell Res Ther; 2020 Aug; 11(1):334. PubMed ID: 32746912
[TBL] [Abstract][Full Text] [Related]
18. The role of NK cells in HIV-1 protection: autologous, allogeneic or both?
Hens J; Jennes W; Kestens L
AIDS Res Ther; 2016; 13():15. PubMed ID: 26997965
[TBL] [Abstract][Full Text] [Related]
19. Development of an induced pluripotent stem cell-specific microRNA assay for detection of residual undifferentiated cells in natural killer cell therapy products.
Chung L; Cogburn LA; Sui L; Dashnau JL
Cytotherapy; 2022 Jul; 24(7):733-741. PubMed ID: 35461759
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of natural killer cells from induced pluripotent stem cells under defined, serum- and feeder-free conditions.
Lupo KB; Moon JI; Chambers AM; Matosevic S
Cytotherapy; 2021 Oct; 23(10):939-952. PubMed ID: 34272175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
